1. Home
  2. NVAX vs SCL Comparison

NVAX vs SCL Comparison

Compare NVAX & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.80

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$46.56

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
SCL
Founded
1987
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
NVAX
SCL
Price
$6.80
$46.56
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
3.3M
179.0K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
3.34%
EPS Growth
N/A
N/A
EPS
2.07
1.98
Revenue
$1,064,651,000.00
$2,303,837,000.00
Revenue This Year
$58.91
$8.79
Revenue Next Year
N/A
$8.14
P/E Ratio
$3.33
$23.93
Revenue Growth
20.27
5.35
52 Week Low
$5.01
$41.82
52 Week High
$11.55
$67.79

Technical Indicators

Market Signals
Indicator
NVAX
SCL
Relative Strength Index (RSI) 47.26 51.38
Support Level $6.36 $47.69
Resistance Level $6.98 $49.49
Average True Range (ATR) 0.22 1.24
MACD 0.06 0.03
Stochastic Oscillator 63.48 41.94

Price Performance

Historical Comparison
NVAX
SCL

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: